1. Advances in liquid biopsy using circulating tumor cells and circulating cell-free tumor DNA for detection and monitoring of breast cancer

   • Xiaofen Zhang
   • Shaoqing Ju
   • Hui Cong

   Review Article 12 June 2019 Pages: 271 - 279

2. Eculizumab in refractory catastrophic antiphospholipid syndrome: a case report and systematic review of the literature

   • Maria Giulia Tinti
   • Vincenzo Carnevale
   • Angelo De Cata

   Review Article 18 June 2019 Pages: 281 - 288

   

3. Adeno-associated virus as a gene therapy vector: strategies to neutralize the neutralizing antibodies

   • Majid Lotfinia
   • Meghdad Abdollahpour-Alitappeh
   • Morteza Karimipoor

   Review Article 03 May 2019 Pages: 289 - 298

   

4. Direct antiviral agents upregulate natural killer cell potential activity in chronic hepatitis C patients

   • Han-ji Jiang
   • Xiao-xiao Wang
   • Bo Feng

   Original Article 20 June 2019 Pages: 299 - 308

   

5. Changes in APRI and FIB-4 in HBeAg-negative treatment-naive chronic hepatitis B patients with significant liver histological lesions receiving 5-year entecavir therapy

   • Ruyu Liu
   • Jiang Guo
   • Yao Xie

   Original Article 20 May 2019 Pages: 309 - 320

   

6. Ex vivo modelling of the formation of inflammatory platelet-leucocyte aggregates and their adhesion on endothelial cells, an early event in sepsis

   • Azzah Alharbi
   • Jonathan P. Thompson
   • Cordula M. Stover

   Original Article Open access 06 September 2018 Pages: 321 - 337

   

7. Anti-domain 1 of beta2-glycoprotein I aids risk stratification in lupus anticoagulant-positive patients

   • Han Guo
   • Yuncong Zhang
   • Rui Qiao

   Original Article 15 May 2019 Pages: 339 - 345

   

8. TNF-β +252 A>G (rs909253) polymorphism is independently associated with presence of autoantibodies in rheumatoid arthritis patients

   • Fabiano Aparecido de Medeiros
   • Daniela Frizon Alfieri
   • Andréa Name Colado Simão

   Original Article 02 May 2019 Pages: 347 - 356

   

9. Iloprost use and medical management of systemic sclerosis-related vasculopathy in Italian tertiary referral centers: results from the PROSIT study

   • Simone Negrini
   • Ottavia Magnani
   • Lorenzo Beretta

   Original Article 15 April 2019 Pages: 357 - 366

   

10. Functional polymorphisms of the receptor for the advanced glycation end product promoter gene in inflammatory bowel disease: a case–control study

    • Rachele Ciccocioppo
    • Sara Bozzini
    • Colomba Falcone

    Original Article 07 June 2019 Pages: 367 - 375

    

11. Expression of tetraspanins NET-6 and CD151 in breast cancer as a potential tumor biomarker

    • Liejun Jiang
    • Xiliu Zhang
    • Huayi Huang

    Original Article 20 April 2019 Pages: 377 - 384

    

12. Circulating soluble levels of MIF in women with breast cancer in the molecular subtypes: relationship with Th17 cytokine profile

    • Guadalupe Avalos-Navarro
    • José Francisco Muñoz-Valle
    • Alicia Del Toro-Arreola

    Original Article 18 May 2019 Pages: 385 - 391

    

13. Mutation analysis of POLE gene in patients with early-onset colorectal cancer revealed a rare silent variant within the endonuclease domain with potential effect on splicing

    • Zora Lasabová
    • Michal Kalman
    • Lukáš Plank

    Original Article 02 May 2019 Pages: 393 - 400

    

14. Neutrocyte-to-lymphocyte ratio predicts the presence of a replicative hepatitis C virus strand after therapy with direct-acting antivirals

    • Anna Wróblewska
    • Beata Lorenc
    • Katarzyna Sikorska

    Short Communication Open access 24 May 2019 Pages: 401 - 406